Financial statements Neupharm Spółka Z Ograniczoną Odpowiedzialnością I Wspólnicy

Balance sheet of Neupharm Spółka Z Ograniczoną Odpowiedzialnością I Wspólnicy

Company deleted from KRS: 2025-03-28

Balance sheet data of NEUPHARM SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ I WSPÓLNICY

Year
2017
2019
2020
2023
Total assets 98 348,62 150 591,76 426 085,27 2 640 589,77
A. Fixed assets 0,00 0,00 0,00 0,00
B. Current assets 98 348,62 150 591,76 426 085,27 2 640 589,77
C. Share capital contributions (basic funds) 0,00 0,00 0,00 0,00
D. Own shares (stocks) 0,00 0,00 0,00 0,00
Total liabilities 98 348,62 150 591,76 426 085,27 2 640 589,77
A. Equity 96 893,53 5 000,00 154 417,50 -335 274,53
B. Liabilities and provisions for liabilities 1 455,09 145 591,76 271 667,77 2 975 864,30
I. Long-term liabilities - - - 0,00
II. Short-term liabilities - - - 2 975 864,30
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.

  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.